Dr. Yu-luen Hsu, M.D. Allergy & Immunology Medicare: Not Enrolled in Medicare Practice Location: 207 S Santa Anita Ave, Suite P-15, San Gabriel, CA 91776 Phone: 626-284-7000 Fax: 626-284-7001 |
News Archive
The U.S. military will end its formal earthquake relief mission in Haiti on June 1, but some assistance will continue after that, Lieutenant General Ken Keen said on Monday, Reuters reports.
The most frequently mutated gene across all types of cancers is a gene called p53. Unfortunately it has been difficult to directly target this gene with drugs. Now a multi-institutional research team, led by Dr. Lewis Cantley and investigators at Weill Cornell Medical College, has identified a family of enzymes they say is crucial for the growth of cancers that have genetic aberrations in p53.
The World Federation of Neurosurgical Societies (WFNS) representing more than 30,000 neurosurgeons, 114 individual societies and 100 nations has launched World Neurosurgery, the specialty's first publication acting as a global forum for not only high level peer reviewed, clinical and laboratory science, but also the social, political, economic, cultural and educational issues that affect research and care delivery regionally and from a global perspective.
Shire plc, the global specialty biopharmaceutical company, announced findings from a post hoc analysis examining emotional lability from Phase 3 study data with Vyvanse®. In this study, Vyvanse demonstrated significant improvement in Attention-Deficit/Hyperactivity Disorder (ADHD) symptoms as measured by the ADHD Rating Scale IV (ADHD-RS IV) and Connors' Parent Rating Scale-Revised Short (CPRS-RS) in children with ADHD aged 6 to 12 years.
CardioKinetix Inc., a medical device company pioneering a catheter-based treatment for heart failure, today announced two-year clinical results for the first-of-its-kind catheter-based Parachute Ventricular Partitioning Device, a Percutaneous Ventricular Restoration (PVR) therapy for patients with ischemic heart failure.
› Verified 3 days ago